In the summer, a mother in Nashville with a seemingly incurable genetic disorder finally found an end to her suffering -- by editing her genome.
Victoria Gray's recovery from sickle cell disease, which had caused her painful seizures, came in a year of breakthroughs in one of the hottest areas of medical research -- gene therapy.
"I have hoped for a cure since I was about 11," the 34-year-old told AFP in an email.
"Since I received the new cells, I have been able to enjoy more time with my family without worrying about pain or an out-of-the-blue emergency."
Over several weeks, Gray's blood was drawn so doctors could get to the cause of her illness -- stem cells from her bone marrow that were making deformed red blood cells.
The stem cells were sent to a Scottish laboratory, where their DNA was modified using Crispr/Cas9 -- pronounced "Crisper" -- a new tool informally known as molecular "scissors."
The genetically edited cells were transfused back into Gray's veins and bone marrow. A month later, she was producing normal blood cells.
Medics warn that caution is necessary but, theoretically, she has been cured.
"This is one patient. This is early results. We need to see how it works out in other patients," said her doctor, Haydar Frangoul, at the Sarah Cannon Research Institute in Nashville.
"But these results are really exciting."
In Germany, a 19-year-old woman was treated with a similar method for a different blood disease, beta thalassemia. She had previously needed 16 blood transfusions per year.
Nine months later, she is completely free of that burden.
For decades, the DNA of living organisms such as corn and salmon has been modified.
But Crispr, invented in 2012, made gene editing more widely accessible. It is much simpler than preceding technology, cheaper and easy to use in small labs.
The technique has given new impetus to the perennial debate over the wisdom of humanity manipulating life itself.
"It's all developing very quickly," said French geneticist Emmanuelle Charpentier, one of Crispr's inventors and the cofounder of Crispr Therapeutics, the biotech company conducting the clinical trials involving Gray and the German patient.
Crispr is the latest breakthrough in a year of great strides in gene therapy, a medical adventure started three decades ago, when the first TV telethons were raising money for children with muscular dystrophy.
Scientists practising the technique insert a normal gene into cells containing a defective gene.
It does the work the original could not -- such as making normal red blood cells, in Victoria's case, or making tumor-killing super white blood cells for a cancer patient.
Crispr goes even further: instead of adding a gene, the tool edits the genome itself.
After decades of research and clinical trials on a genetic fix to genetic disorders, 2019 saw a historic milestone: approval to bring to market the first gene therapies for a neuromuscular disease in the US and a blood disease in the European Union.
They join several other gene therapies -- bringing the total to eight -- approved in recent years to treat certain cancers and an inherited blindness.
Serge Braun, the scientific director of the French Muscular Dystrophy Association, sees 2019 as a turning point that will lead to a medical revolution.
"Twenty-five, 30 years, that's the time it had to take," he told AFP from Paris.
"It took a generation for gene therapy to become a reality. Now, it's only going to go faster."
Just outside Washington, at the National Institutes of Health (NIH), researchers are also celebrating a "breakthrough period."
"We have hit an inflection point," said Carrie Wolinetz, NIH's associate director for science policy.
These therapies are exorbitantly expensive, however, costing up to $2 million -- meaning patients face grueling negotiations with their insurance companies.
They also involve a complex regimen of procedures that are only available in wealthy countries.
Gray spent months in hospital getting blood drawn, undergoing chemotherapy, having edited stem cells reintroduced via transfusion -- and fighting a general infection.
"You cannot do this in a community hospital close to home," said her doctor.
However, the number of approved gene therapies will increase to about 40 by 2022, according to MIT researchers.
They will mostly target cancers and diseases that affect muscles, the eyes and the nervous system.
Another problem with Crispr is that its relative simplicity has triggered the imaginations of rogue practitioners who don't necessarily share the medical ethics of Western medicine.
Last year in China, scientist He Jiankui triggered an international scandal -- and his excommunication from the scientific community -- when he used Crispr to create what he called the first gene-edited humans.
The biophysicist said he had altered the DNA of human embryos that became twin girls Lulu and Nana.
His goal was to create a mutation that would prevent the girls from contracting HIV, even though there was no specific reason to put them through the process.
"That technology is not safe," said Kiran Musunuru, a genetics professor at the University of Pennsylvania, explaining that the Crispr "scissors" often cut next to the targeted gene, causing unexpected mutations.
"It's very easy to do if you don't care about the consequences," Musunuru added.
Despite the ethical pitfalls, restraint seems mainly to have prevailed so far.
The community is keeping a close eye on Russia, where biologist Denis Rebrikov has said he wants to use Crispr to help deaf parents have children without the disability.
There is also the temptation to genetically edit entire animal species -- malaria-causing mosquitoes in Burkina Faso or mice hosting ticks that carry Lyme disease in the US.
The researchers in charge of those projects are advancing carefully, however, fully aware of the unpredictability of chain reactions on the ecosystem.
6 Nov, 2019
6 Nov, 2019
6 Nov, 2019
6 Nov, 2019
6 Nov, 2019
Charpentier doesn't believe in the more dystopian scenarios predicted for gene therapy, including American "biohackers" injecting themselves with Crispr technology bought online.
"Not everyone is a biologist or scientist," she said.
And the possibility of military hijacking to create soldier-killing viruses or bacteria that would ravage enemies' crops?
Charpentier thinks that technology generally tends to be used for the better.
"I'm a bacteriologist -- we've been talking about bioterrorism for years," she said. "Nothing has ever happened."
- Anaplastic Large Cell Lymphoma Alcl Therapeutics Market is Set to Experience Revolutionary Growth by 2026 - Cole of Duty - July 16th, 2020
- 'I don't have much time. I need a miracle' why stem cell donors are urgently needed - The Times - July 15th, 2020
- With rise in Covid cases, Surat to add 1,570 beds in 2 hospitals - The Indian Express - July 15th, 2020
- It's past time to treat international students as more than just money makers for universities - Massive Science - July 15th, 2020
- Scientists have made an important discovery for the treatment of male infertility - The Saxon - July 14th, 2020
- Tummy Ache Turns Out To Be Cancer, ER Visit During Pandemic Was Critical Decision - CBS Denver - July 14th, 2020
- One common infection could kill our baby girl but one simple act could change her life forever - The Sun - July 14th, 2020
- Top 10 Most Popular Stem Cell Treatments of 2020 - July 13th, 2020
- Coronavirus updates: California to release 8,000 inmates; masks 'only way' to prevent another shutdown, Texas Gov. says - Times Record News - July 13th, 2020
- Actor Nick Cordero Has Died from COVID-19 Complications After 13 Weeks in the Hospital - Yahoo India News - July 12th, 2020
- Ryan Anthony: A local trumpet prodigy who went on to play big stages and raise funds for cancer research - The San Diego Union-Tribune - July 11th, 2020
- The 'Teeter-Totter' of Blood Draws - Curetoday.com - July 11th, 2020
- In the middle of pandemic, this young mom fights second cancer diagnosis - Omaha World-Herald - July 11th, 2020
- R3 International Now Offering Stem Cell Therapy Program for Crohns Disease, IBD and Ulcerative Colitis - PR Web - July 10th, 2020
- Eucalyptus necklace and other unproven Covid-19 cures raise alarm in Indonesia - The Star Online - July 10th, 2020
- Surat: Engineer falls to death from tenth floor of under construction Covid hospital - The Indian Express - July 10th, 2020
- Tribute to Andra Campbell after five-year cancer battle | Romsey Advertiser - Romsey Advertiser - July 10th, 2020
- IML conducts the 5th National Convention on Medicine and Law - ETHealthworld.com - July 10th, 2020
- R3 International Now Offering Stem Cell Therapy Program for Crohns Disease, IBD and Ulcerative Colitis - Benzinga - July 9th, 2020
- Stem Cell Therapy Market : Global Forecast over 2025 Cole of Duty - Cole of Duty - July 9th, 2020
- Whatever happened to baby Owen? - The Herald-News - July 9th, 2020
- University of Miami Miller School-led technology paves way for islet regeneration in human pancreas - Newswise - July 9th, 2020
- Here's Why Mesoblast Stock Rose Over 18% Today - The Motley Fool - July 9th, 2020
- Eucalyptus necklace and other unproven Covid-19 cures raise alarm in Indonesia - The Straits Times - July 9th, 2020
- Global Organ Preservation Market Future Demand (COVID 19 Impact Analysis) & Growth Analysis with Forecast up to 2027 - Cole of Duty - July 9th, 2020
- First time ever successful operation with a single-use endoscope on immunodepressed child - Emergency-Live - July 4th, 2020
- College Kids Are Apparently Playing a Game Where They Try to Catch COVID - Futurism - July 3rd, 2020
- A Shot of This Gene Editing Serum Appears to Prevent Heart Disease in Monkeys - Futurism - July 3rd, 2020
- Katharine McPhee reveals frustrations with husband David Foster in new documentary - Wonderwall - July 3rd, 2020
- Jada Pinkett Smith denies August Alsina's claim they had years-long relationship with Will Smith's blessing - Wonderwall - July 3rd, 2020
- Global Bronchopulmonary Dysplasia Treatment Market Projected to Witness a Measurable Downturn; COVID-19 Outbreak Remains a Threat to Growth in the... - July 3rd, 2020
- Its not just the lungs: COVID-19 can affect the brain and heart of those infected, researchers say - WITI FOX 6 Milwaukee - July 2nd, 2020
- Inequality in COVID-19 Has Other Dangerous Consequences - Fox and Hounds Daily - July 2nd, 2020
- Five Year-old Boy with Covid-19 Saves Sisters Life in Thailand - Chiang Rai Times - July 2nd, 2020
- Anniversary in the year of the coronavirus: 100 years of health protection at Audi - Automotive World - July 2nd, 2020
- What causes joint pain and how to slow down their defeat. Responsible orthopedic trauma - The Saxon - July 2nd, 2020
- In the middle of a pandemic, a young Minnesota mother fights her second cancer diagnosis - Minneapolis Star Tribune - June 27th, 2020
- Over 2,000 patients get stem cell treatment for COVID-19 in UAE | MEO - Middle East Online - June 27th, 2020
- Six-year-old given heroes welcome by his classmates after months of life-saving cancer treatment in Singapore - Yahoo Finance UK - June 27th, 2020
- BLM in STEM: We can't forget that scientific research is steeped in colonialism - Varsity Online - June 27th, 2020
- Exporting the Virus - The Investigative Fund - June 27th, 2020
- R3 International Offering Stem Cell Therapy Program for Anti Aging in Mexico - Yahoo Finance - June 26th, 2020
- 5-year-old Thai boy with COVID-19 saves sisters life with his stem cells - Yahoo Singapore News - June 26th, 2020
- Coronavirus Attacks the Lungs. A Federal Agency Just Halted Funding for New Lung Treatments. - The New York Times - June 26th, 2020
- Professor: Looming COVID Surge on "Verge of Being Apocalyptic" - Futurism - June 26th, 2020
- UAE stem cell therapy for coronavirus treats over 2000 patients, 1200 fully recover - MENAFN.COM - June 26th, 2020
- Mini-Organ Research Reveals What COVID-19 Does to the Body - Futurism - June 23rd, 2020
- Who is Nick Cordero and how is he doing after his coronavirus battle? - The Sun - June 23rd, 2020
- My Friend Was Struck by ALS. Heres How Hes Fighting Back - WIRED - June 23rd, 2020
- Family of 18-year-old Doncaster boy who died of cancer raise thousands for charities that helped him - Doncaster Free Press - June 23rd, 2020
- Michael Schumacher: Everything There Is to Know About His Health, Condition, and Accident - Essentially Sports - June 22nd, 2020
- Anonymous US stem cell donor saves the life of Norwich girl - Eastern Daily Press - June 19th, 2020
- British boy who came to Singapore for treatment for aggressive cancer is 'almost ready to go home' - CNA - June 19th, 2020
- Momenta clears a PhII hurdle on nipo but one big rival remains well in the lead in this packed field - Endpoints News - June 16th, 2020
- Leukemia Therapeutic Market to Witness Exponential Rise in Revenue Share During the Forecast Period 2015 to 2021 - The Canton Independent Sentinel - June 16th, 2020
- Want to save a life? Try to give blood. Then keep trying. - Tampa Bay Times - June 16th, 2020
- Rare disease startup NFlection scores $20M in Series A haul; Gilead partner Galapagos signs pact with Oxford biotech - Endpoints News - June 16th, 2020
- Gene Therapy and Editing : Novel options for inherited retinal blindness - ETHealthworld.com - June 14th, 2020
- Why Do Some People Get Sick All the Time, While Others Stay in Freakishly Good Health? - Discover Magazine - June 14th, 2020
- If You Invested $1,000 in Fate Therapeutics' IPO, This Is How Much Money You'd Have Now - The Motley Fool - June 13th, 2020
- A Perfect Match: Marcus grad honors late father by saving lives - The Cross Timbers Gazette - June 13th, 2020
- Chase and Sadie get heartbreaking results as his cancer spreads: 'Promise me you will try' - IndyStar - June 13th, 2020
- Irish dad with rare form of cancer would have died within a week if he didn't go to hospital - Irish Mirror - June 13th, 2020
- Types of cancers making people more vulnerable to Covid-19 - Nursing in Practice - June 13th, 2020
- They Put Him Back Together Again - University of Michigan Health System News - June 12th, 2020
- I thought it was just a rash but rare cancer now covers 90% of my skin splitting my hands and feet open - The Sun - June 12th, 2020
- 'I was tired and sore and I thought I had a really bad cold' - 9Honey - June 12th, 2020
- Westerleigh resident is alive because of stem cell therapy by his doctor -- for free. Heres his story. - SILive.com - June 12th, 2020
- Vancouver Island father dies of leukemia after battle to find mixed-race stem cell donor - Coast Mountain News - June 12th, 2020
- Thalassemia Treatment Market: Chelation Therapy to be Highly Lucrative Segment - BioSpace - June 12th, 2020
- Amyotrophic Lateral Sclerosis Treatment Market Analysis and Forecast to 2026 || Top Growing Companies are ViroMed Co., Ltd, Ionis Pharmaceuticals,... - June 12th, 2020
- Could these senolytic drugs halt the spread of COVID-19? - Health Europa - June 11th, 2020
- Nick Cordero's Wife Says He Had A 'Rocky Night' After His Fever Spiked - iHeartRadio - June 11th, 2020
- Doctors revealed details of the new rescue of Michael Schumacher - The Times Hub - June 11th, 2020
- Autologous Bone Marrow Transplantation and Metformin, a Hope for the Cure of Multiple Sclerosis - Gilmore Health News - June 11th, 2020
- Here Are a Bunch of Photos of Cops Not Wearing Masks - Futurism - June 9th, 2020
- Lies and Hypocrisy: Anti-Abortion Arguments to Restrict the Abortion Pill - Ms. Magazine - June 9th, 2020
- Cryo-Cell to Donate 50,000 Face Masks to OBGYN Practices and Patients Around the Country Amidst COVID-19 - PR Web - June 9th, 2020
- Coronavirus: Abu Dhabi invests Dh3.6m in new technology to boost Covid-19 fight - The National - June 9th, 2020
- Bald men at higher risk of having severe coronavirus, shocking new research suggests - Express - June 5th, 2020